Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Neoplasms × Cholecalciferol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vitamin D Deficiency 2 Prostatic Neoplasms 2 Triple Negative Breast Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Osteoporosis Secondary 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Biphenotypic, Acute 1 Colonic Neoplasms 1

Interventions

Gemcitabine 56 130-nm albumin-bound paclitaxel 28 Specimen Handling 18 Magnetic Resonance Spectroscopy 18 Taxes 17 Albumin-Bound Paclitaxel 17 Leucovorin 16 Fluorouracil 16 pembrolizumab 15 Oxaliplatin 15 Drug Therapy 14 Irinotecan 12 Cyclophosphamide 11 Biopsy 11 fludarabine 10 Blood Specimen Collection 10 olaparib 7 irinotecan sucrosofate 7 folfirinox 6 Cetuximab 6 Capecitabine 6 dehydroftorafur 5 Radiotherapy 5 Radiosurgery 5 Magnetic Resonance Imaging 5 Cisplatin 5 Bevacizumab 5 sintilimab 4 durvalumab 4 camrelizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06757244 2025-03-18

DOVIPA

Hopital Foch

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡